Ironwood Pharmaceuticals
Stock Forecast, Prediction & Price Target
Ironwood Pharmaceuticals Financial Estimates
Ironwood Pharmaceuticals Revenue Estimates
Ironwood Pharmaceuticals EBITDA Estimates
Ironwood Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $413.75M N/A | $410.59M -0.76% | $442.73M 7.82% | Avg: $464.56M Low: $435.06M High: $498.30M avg. 4.93% | Avg: $547.32M Low: $524.57M High: $572.69M avg. 17.81% | Avg: $698.5M Low: $669.46M High: $730.87M avg. 27.62% | Avg: $636M Low: $609.56M High: $665.47M avg. -8.94% |
Net Income
% change YoY
| $528.44M N/A | $175.06M -66.87% | $-1.00B -672.49% | Avg: $99.76M Low: $104.14M High: $152.32M avg. 109.95% | Avg: $120.05M Low: $122.03M High: $136.78M avg. 20.33% | Avg: $155.43M Low: $147.03M High: $164.79M avg. 29.47% | Avg: $0 Low: $0 High: $0 avg. -100% |
EBITDA
% change YoY
| $232.94M N/A | $259.83M 11.54% | $-924.86M -455.93% | Avg: $219.55M Low: $205.61M High: $235.49M avg. 123.73% | Avg: $258.66M Low: $247.91M High: $270.65M avg. 17.81% | Avg: $330.10M Low: $316.38M High: $345.40M avg. 27.62% | Avg: $300.57M Low: $288.07M High: $314.50M avg. -8.94% |
EPS
% change YoY
| $3.26 N/A | $1.13 -65.33% | -$6.45 -670.79% | Avg: $0.78 Low: $0.67 High: $0.98 avg. 112.14% | Avg: $0.83 Low: $0.79 High: $0.88 avg. 5.95% | Avg: $1 Low: $0.95 High: $1.06 avg. 20.48% | Avg: $0 Low: $0 High: $0 avg. -100% |
Operating Expenses
% change YoY
| $181.53M N/A | $160.25M -11.72% | $1.28B 700.81% | Avg: $149.85M Low: $140.33M High: $160.73M avg. -88.32% | Avg: $176.54M Low: $169.20M High: $184.72M avg. 17.81% | Avg: $225.30M Low: $215.94M High: $235.75M avg. 27.62% | Avg: $205.14M Low: $196.62M High: $214.65M avg. -8.94% |
FAQ
What is Ironwood Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 39.94% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is 104.14M, average is 99.76M and high is 152.32M.
What is Ironwood Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 10.35% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is $435.06M, average is $464.56M and high is $498.30M.
What is Ironwood Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 34.64% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is $0.67, average is $0.78 and high is $0.98.
What is the best performing analyst?
In the last twelve months analysts have been covering Ironwood Pharmaceuticals stock. The most successful analyst is Mohit Bansal.